Kanabo Research Signs Partnership Agreement with Jupiter Research

Rehovot, Israel (ots/PRNewswire) -

Kanabo Research, a Tel-Aviv-based medical cannabis R&D company,
announced that it has signed a partnership agreement with Jupiter
Research, an innovative manufacturer of high-performance inhalation
hardware and technology for plant based extracts.

(Photo:
https://mma.prnewswire.com/media/657554/KANABO_Mark_and_Avihu.jpg )

The partnership agreement was officially signed during the
CannTech conference held this week in Tel Aviv with the presence of
senior officials from Jupiter, visiting from Phoenix, Arizona.

As part of the strategic partnership, Kanabo licensed Jupiter's L9
vaporizer platform under the VapePod brand. Kanabo and Jupiter
collaborated to fine tune the vaporizer for medical use, and then
Kanabo worked to have VapePod approved as a medical device by the
Israeli Ministry of Health. Kanabo Research has the exclusive rights
to distribute the certified VapePod in Israel, Europe, South Africa,
Australia, and New Zealand.

Jupiter Research has developed three superior vaporizer platforms
that utilize CCELL ceramic core technology for unparalleled vapor
performance. Jupiter's vaporizers are preferred by leading companies,
and are sold in the US market and globally. Due to their high quality
vaporizers, the company has achieved explosive growth.

Moving forward, Kanabo and Jupiter will work together to research
and develop the next generation of "smart" vaporizers for the global
medical cannabis market.

"Our partnership agreement with Jupiter Research is an important
strategic step in Kanabo's global expansion," said Avihu Tamir,
Founder and CEO of Kanabo Research. "Jupiter's superior technology
and high presence in the US market combined with our medical
validation and formulation capabilities in Israel will allow us to
create a suitable infrastructure for rapid growth and accelerate our
entry into new markets."

"Through years of research, development and testing, we've
developed a product that meets the demands of today's medical
consumer. We are honored to partner with Kanabo Research to bring the
VapePod to market, featuring revolutionary CCELL technology," said
Mark Scatterday, President of Jupiter Research.

It should also be noted that the Israeli Ministry of Health has
granted initial approval as a medical device to Kanabo's VapePod
vaporizer. This action makes Israel the first county in the world to
grant medical device approval to a vaporizer for the use of medical
cannabis extracts and formulations.

www.jupiterresearch.com

ots Originaltext: Kanabo Research
Im Internet recherchierbar: http://www.presseportal.de

Contact:
Gil Kraiem
+972-50-5703090
kababoresearch.com & jupiterresearch.com

Original-Content von: Kanabo Research, übermittelt durch news aktuell